FDA Approves Vectibix to Treat Patients with Metastatic Colorectal Cancer

Armen Hareyan's picture

Vectibix treats colorectal cancer that's spread

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved Vectibix

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.